Includes ACEi(-pril) and ARB (-sartan)

Effect

• Proteinuria reduction: Often 30–40% reduction, independent of BP-lowering effect.
• Renal protection: Slows CKD progression (landmark trials in diabetic nephropathy, IgA nephropathy).
• Cardiovascular benefit: Less LV hypertrophy, lower CV events.